Skip to main content
Equibles
MEDS logo

MEDS · DataMeds AI, Inc. · Analyst Estimates

Track MEDS — free

Use MEDS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MEDS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.87 +0.00 (+0.07%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 17, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within twelve months from the date these unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 17, 2026
Market Cap
$2.65M
Shares
3.06M

Analyst Estimates

Compare analyst forecasts for DataMeds AI, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Source collection is delayed; the retained verified snapshot may not include newer publications.

Consensus not yet available

Source collection is delayed; the retained verified snapshot may not include newer publications.

Key facts CIK 2030763 CUSIP 949503205 Visit website Investor relations